NDC 71335-2981 – Buprenorphine and Naloxone

Buprenorphine Hydrochloride 8 mg/1; Naloxone Hydrochloride Dihydrate 2 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC71335-2981

Product details

Brand name
Buprenorphine and Naloxone
Generic name
Buprenorphine and Naloxone
Labeler
Bryant Ranch Prepack
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA205601
Marketed since
April 13, 2020
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (10)

Package NDCDescriptionSince
71335-2981-042 TABLET in 1 BOTTLE, PLASTIC (71335-2981-0)Apr 16, 2026
71335-2981-130 TABLET in 1 BOTTLE, PLASTIC (71335-2981-1)Apr 16, 2026
71335-2981-260 TABLET in 1 BOTTLE, PLASTIC (71335-2981-2)Apr 16, 2026
71335-2981-390 TABLET in 1 BOTTLE, PLASTIC (71335-2981-3)Apr 16, 2026
71335-2981-4120 TABLET in 1 BOTTLE, PLASTIC (71335-2981-4)Apr 16, 2026
71335-2981-514 TABLET in 1 BOTTLE, PLASTIC (71335-2981-5)Apr 16, 2026
71335-2981-628 TABLET in 1 BOTTLE, PLASTIC (71335-2981-6)Apr 16, 2026
71335-2981-76 TABLET in 1 BOTTLE, PLASTIC (71335-2981-7)Dec 8, 2025
71335-2981-810 TABLET in 1 BOTTLE, PLASTIC (71335-2981-8)Oct 27, 2025
71335-2981-921 TABLET in 1 BOTTLE, PLASTIC (71335-2981-9)Apr 16, 2026

Other Buprenorphine and Naloxone products